Associated Banc-Corp’s AbbVie ABBV Stock Holding History

Associated Banc-Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.67M	Sell	39,861 -914	-2%	-$203K	0.23%	97
2025 Q4	$9.32M	Sell	40,775 -2,967	-7%	-$676K	0.24%	93
2025 Q3	$10.1M	Buy	43,742 +9,099	+26%	+$1.85M	0.27%	87
2025 Q2	$6.43M	Buy	34,643 +600	+2%	+$112K	0.18%	106
2025 Q1	$7.13M	Sell	34,043 -1,639	-5%	-$319K	0.22%	96
2024 Q4	$6.34M	Sell	35,682 -3,741	-9%	-$688K	0.19%	102
2024 Q3	$7.79M	Buy	39,423 +3,228	+9%	+$602K	0.23%	93
2024 Q2	$6.21M	Sell	36,195 -1,536	-4%	-$254K	0.19%	109
2024 Q1	$6.87M	Buy	37,731 +1,286	+4%	+$222K	0.22%	102
2023 Q4	$5.65M	Buy	36,445 +183	+0.5%	+$26.7K	0.2%	109
2023 Q3	$5.41M	Sell	36,262 -1,472	-4%	-$216K	0.21%	102
2023 Q2	$5.08M	Sell	37,734 -272	-0.7%	-$39.9K	0.19%	113
2023 Q1	$6.06M	Sell	38,006 -438	-1%	-$67K	0.24%	98
2022 Q4	$6.21M	Sell	38,444 -559	-1%	-$85.7K	0.26%	98
2022 Q3	$5.24M	Sell	39,003 -793	-2%	-$114K	0.24%	98
2022 Q2	$6.09M	Sell	39,796 -2,059	-5%	-$315K	0.27%	91
2022 Q1	$6.79M	Sell	41,855 -762	-2%	-$111K	0.26%	91
2021 Q4	$5.77M	Sell	42,617 -1,732	-4%	-$205K	0.21%	103
2021 Q3	$4.78M	Sell	44,349 -2,371	-5%	-$271K	0.19%	110
2021 Q2	$5.26M	Sell	46,720 -102	-0.2%	-$11.5K	0.21%	107
2021 Q1	$3.57M	Sell	46,822 -42,889	-48%	-$4.59M	0.22%	96
2020 Q4	$9.61M	Sell	89,711 -6,389	-7%	-$614K	0.38%	71
2020 Q3	$8.42M	Sell	96,100 -4,741	-5%	-$446K	0.36%	75
2020 Q2	$9.9M	Buy	100,841 +9,551	+10%	+$841K	0.45%	62
2020 Q1	$6.96M	Buy	91,290 +42,263	+86%	+$3.6M	0.37%	76
2019 Q4	$4.34M	Sell	49,027 -2,307	-4%	-$192K	0.22%	105
2019 Q3	$3.89M	Buy	51,334 +47	+0.1%	+$3.22K	0.21%	110
2019 Q2	$3.73M	Sell	51,287 -1,848	-3%	-$145K	0.2%	109
2019 Q1	$4.28M	Sell	53,135 -7,465	-12%	-$611K	0.25%	101
2018 Q4	$5.59M	Buy	60,600 +7,696	+15%	+$677K	0.36%	78
2018 Q3	$5M	Sell	52,904 -251	-0.5%	-$23.8K	0.28%	97
2018 Q2	$4.92M	Sell	53,155 -1,382	-3%	-$135K	0.29%	96
2018 Q1	$5.16M	Sell	54,537 -6,206	-10%	-$682K	0.29%	92
2017 Q4	$5.88M	Sell	60,743 -2,624	-4%	-$247K	0.32%	80
2017 Q3	$5.63M	Sell	63,367 -2,540	-4%	-$193K	0.31%	81
2017 Q2	$4.78M	Sell	65,907 -17,518	-21%	-$1.18M	0.27%	88
2017 Q1	$5.44M	Sell	83,425 -11,502	-12%	-$723K	0.32%	79
2016 Q4	$5.94M	Sell	94,927 -2,070	-2%	-$126K	0.37%	71
2016 Q3	$6.12M	Sell	96,997 -1,375	-1%	-$89K	0.39%	74
2016 Q2	$6.09M	Sell	98,372 -7,123	-7%	-$434K	0.39%	73
2016 Q1	$6.03M	Buy	105,495 +2,145	+2%	+$120K	0.4%	74
2015 Q4	$6.12M	Buy	103,350 +44	+0%	+$2.53K	0.4%	72
2015 Q3	$5.62M	Buy	103,306 +1,175	+1%	+$76.5K	0.39%	72
2015 Q2	$6.86M	Sell	102,131 -6,489	-6%	-$424K	0.44%	68
2015 Q1	$6.36M	Sell	108,620 -39,664	-27%	-$2.4M	0.4%	74
2014 Q4	$9.7M	Sell	148,284 -8,216	-5%	-$518K	0.61%	54
2014 Q3	$9.04M	Sell	156,500 -7,400	-5%	-$411K	0.59%	55
2014 Q2	$9.25M	Sell	163,900 -8,500	-5%	-$446K	0.6%	52
2014 Q1	$8.86M	Buy	172,400 +7,307	+4%	+$369K	0.61%	52
2013 Q4	$8.72M	Buy	165,093 +7,235	+5%	+$356K	0.63%	52
2013 Q3	$7.06M	Buy	157,858 +1,922	+1%	+$85.2K	0.56%	55
2013 Q2	$6.45M	Buy	+155,936	New	+$6.82M	0.53%	59

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Associated Banc-Corp's ABBV Position: Q1 2026 in Review

Associated Banc-Corp reduced its AbbVie (ABBV) stake by 2.2% in Q1 2026, selling an estimated $203K and leaving 39,861 shares worth $8.67M. The position accounts for 0.23% of the portfolio, ranked #97.

Associated Banc-Corp first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.1M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Associated Banc-Corp held 39,861 shares of AbbVie worth $8.67M as of Q1 2026.
Associated Banc-Corp sold 914 AbbVie shares in Q1 2026, an estimated $203K.
AbbVie made up 0.23% of Associated Banc-Corp's portfolio in Q1 2026, its #97 holding.
Associated Banc-Corp first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Associated Banc-Corp's AbbVie position peaked at $10.1M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.